cro.directory
← Compare landing

Scimega Research vs Volumetryx

Side-by-side profile data from each company listing. Missing fields stay blank rather than filled with assumptions.

CategoryScimega ResearchVolumetryx
SummaryCanadian oncology-focused CRO running Phase 1, 2 and 3 trials through privileged site relationships across Canada. Offers Reverse Feasibility, Health Canada CTA/IND strategy, provincial ethics approval support and CRA monitoring for small and mid-sized biopharma sponsors.Radiologist-founded oncology imaging CRO offering DICOM collect & hold, central reads by subspecialist radiologists, and AI-assisted volumetric analysis for Phase I/II trials. FDA 21 CFR Part 11, HIPAA, and GDPR compliant with 24–72 hour turnaround.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Clinical Operations
  • Regulatory Affairs
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Clinical Operations
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
ModalitiesData not yet provided.Data not yet provided.
Indications
  • Oncology
  • Oncology
Phases
  • Phase I
  • Phase II
  • Phase III
  • Phase I
  • Phase II
Sourcing modelsData not yet provided.
  • Full-Service Outsourcing (FSO)
Locations
  • Laval, Laval, Québec, Canada
Data not yet provided.
CertificationsData not yet provided.
  • FDA · Identifier: 21 CFR Part 11
  • HIPAA · Identifier: HIPAA
  • GDPR · Identifier: GDPR

Find similar companies

Scimega Research alternatives · Volumetryx alternatives

Markdown mirror: /compare/scimega/volumetryx.md